Puma Biotechnology Inc (NAS:PBYI)
$ 3.3 0.42 (14.58%) Market Cap: 161.86 Mil Enterprise Value: 143.25 Mil PE Ratio: 18.33 PB Ratio: 3.30 GF Score: 57/100

Q3 2020 Puma Biotechnology Inc Earnings Call Transcript

Nov 05, 2020 / 09:30PM GMT
Release Date Price: $8.47 (-3.09%)
Operator

Greetings, ladies and gentlemen. Thank you for joining the Puma Biotechnology third quarter earnings call. (Operator Instructions) Please note that this conference is being recorded. I will now turn the conference over to your host, Mariann Ohanesian, Senior Director. Thank you. You may begin.

Mariann Ohanesian
Puma Biotechnology, Inc. - Senior Director of IR

Thank you, Diego. Good afternoon, and welcome to Puma's conference call to discuss our financial results for the third quarter of 2020. Joining me on the call today are Alan Auerbach, Chief Executive Officer, President, and Chairman of the Board of Puma Biotechnology; Maximo Nougues, Chief Financial Officer; and Jeff Ludwig, Chief Commercial Officer.

After market close today, Puma issued a news release detailing third quarter 2020 financial results. That news release, the slides that Alan and Jeff will refer to, and a webcast of this call are accessible via the homepage and Investor sections of our website at pumabiotechnology.com. The webcast and presentation slides will be archived on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot